Table 2.
Characteristics of two cohorts of patients
| Characteristics | NSCLC Cohort
|
CC Cohort
|
||
|---|---|---|---|---|
| Distant failure (+) | Distant failure (−) | Distant failure (+) | Distant failure (−) | |
| Age, years | ||||
| mean ± SD | 69.9 ± 9.2 | 70.2 ± 10.2 | 41.6 ± 11.7 | 49.1 ± 11.3 |
| Median (range) | 69.0 (57.0–89.0) | 71.0 (54.0–90.0) | 38.0 (29.0–70.0) | 49.0 (26.0–72) |
| Ethnicity, No. (%) | ||||
| Caucasian | 9 (75.0) | 27 (75.0) | 6 (42.9) | 12 (31.6) |
| Hispanic | 0 (0) | 1 (1.3) | 2 (14.3) | 15 (39.5) |
| African American | 3 (25.0) | 7 (19.4) | 5 (35.7) | 10 (26.3) |
| Asian | 0 (0) | 1 (1.3) | 1 (7.1) | 0 (0) |
| Other | 0 (0) | 0 (0) | 0 (0) | 1 (2.6) |
| Clinical tumor size, mm, No. (%) | ||||
| ≤ 10 | 1 (8.3) | 0 (0) | 0 (0) | 1 (2.6) |
| 11-30 | 6 (50.0) | 26 (72.2) | 2 (14.3) | 4 (10.6) |
| 31-50 | 5 (41.7) | 9 (25.0) | 9 (64.3) | 20 (52.6) |
| 51-70 | 0 (0) | 1 (1.3) | 2 (14.3) | 9 (23.6) |
| > 71 | 0 (0) | 0 (0) | 1 (7.1) | 4 (10.6) |
| Histology, No. (%) | ||||
| Adenocarcinoma | 6 (50.0) | 17 (47.3) | 1 (7.1) | 4 (10.6) |
| Squamous cell carcinoma | 5 (41.7) | 12 (33.3) | 11 (78.6) | 33 (86.8) |
| Other | 1 (8.3) | 7 (19.4) | 2 (14.3) | 1 (2.6) |
| Stage, No. (%) | ||||
| IA | 5 (41.7) | 30 (83.3) | 0 (0) | 0 (0) |
| IB | 7 (58.3) | 6 (16.7) | 4 (28.6) | 12 (31.6) |
| IIA | 0 (0) | 0 (0) | 1 (7.1) | 3 (7.9) |
| IIB | 0 (0) | 0 (0) | 7 (50.0) | 15 (39.5) |
| IIIB | 0 (0) | 0 (0) | 0 (0) | 6 (15.8) |
| IVA | 0 (0) | 0 (0) | 2 (14.3) | 2 (5.2) |
NOTE. Stages in NSCLC and CC are determined by the TNM and Federation of Gynecology and Obstetrics (FIGO) staging system, respectively.
Abbreviations: NSCLC, non-small cell lung cancer; CC: cervix cancer; SD: standard deviation.